Antiviral activity of filibuvir in combination with pegylated interferon ALFA-2A and ribavirin for 28 days in treatment naive patients chronically infected with HCV genotype 1

Authors
Category Primary study
JournalJournal of Hepatology
Year 2009
This article has no abstract
Epistemonikos ID: 3ff66412cea8693a7662926e11048a29217b6c33
First added on: Feb 28, 2025